Quantum BioPharma Ltd. (QNTM) Stock Overview
Explore Quantum BioPharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Quantum BioPharma Ltd. (QNTM)
Key Financials
Key Financials
Market Cap
16.7M
P/E Ratio
-0.45
EPS (TTM)
$-8.25
ROE
-6.22%
QNTM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Quantum BioPharma Ltd. (QNTM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.45 and a market capitalization of 16.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.